{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:29:25Z","timestamp":1793651365864,"version":"4.5.1"},"reference-count":213,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.micpath.2026.108871","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:03:00Z","timestamp":1791475380000},"page":"108871","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Combating antimicrobial resistance: Emerging non-traditional therapeutics, clinical translation challenges, and future perspectives"],"prefix":"10.1016","volume":"221","author":[{"given":"Zahra","family":"Shareef","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hafiz Iftikhar","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amjad Islam","family":"Aqib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Sibghat Ullah","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3571-8226","authenticated-orcid":false,"given":"Shafeeq Ur","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2026.108871_bib1","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1080\/1040841X.2020.1813687","article-title":"Antimicrobial resistance: more than 70 years of war between humans and bacteria","volume":"46","author":"Nadeem","year":"2020","journal-title":"Crit. Rev. Microbiol."},{"key":"10.1016\/j.micpath.2026.108871_bib2","doi-asserted-by":"crossref","first-page":"S122","DOI":"10.1038\/nm1145","article-title":"Antibacterial resistance worldwide: causes, challenges and responses","volume":"10","author":"Levy","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.micpath.2026.108871_bib3","doi-asserted-by":"crossref","first-page":"10715","DOI":"10.1039\/C5TC02043C","article-title":"Multi-phase semicrystalline microstructures drive exciton dissociation in neat plastic semiconductors","volume":"3","author":"Paquin","year":"2015","journal-title":"J. Mater. Chem. C"},{"key":"10.1016\/j.micpath.2026.108871_bib4","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nrmicro3380","article-title":"Molecular mechanisms of antibiotic resistance","volume":"13","author":"Blair","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.micpath.2026.108871_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.71077","article-title":"The global challenge of antimicrobial resistance : mechanisms , case studies , and mitigation approaches","volume":"8","author":"Nazir","year":"2025","journal-title":"Health Sci. Rep."},{"key":"10.1016\/j.micpath.2026.108871_bib6","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Articles Global burden of bacterial antimicrobial resistance in 2019 : a systematic analysis","volume":"399","author":"Collaborators","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.micpath.2026.108871_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.glmedi.2024.100081","article-title":"Antimicrobial resistance: impacts, challenges, and future prospects","volume":"2","author":"Ahmed","year":"2024","journal-title":"J. Med. Surg. Public Health"},{"key":"10.1016\/j.micpath.2026.108871_bib8","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1086\/533452","article-title":"Federal funding for the study of antimicrobial resistance in nosocomial pathogens: No ESKAPE","volume":"197","author":"Rice","year":"2008","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.micpath.2026.108871_bib9","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1139\/cjm-2018-0275","article-title":"Horizontal transfer of antibiotic resistance genes in clinical environments","volume":"65","author":"Lerminiaux","year":"2019","journal-title":"Can. J. Microbiol."},{"key":"10.1016\/j.micpath.2026.108871_bib10","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s00284-016-1036-6","article-title":"Phenotypic tests for the detection of \u03b2-lactamase-producing enterobacteriaceae isolated from different environments","volume":"73","author":"de Oliveira","year":"2016","journal-title":"Curr. Microbiol."},{"key":"10.1016\/j.micpath.2026.108871_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pmed.1002184","article-title":"Will 10 million people die a year due to antimicrobial resistance by 2050?","volume":"13","author":"de Kraker","year":"2016","journal-title":"PLoS Med."},{"key":"10.1016\/j.micpath.2026.108871_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2019.105087","article-title":"Synergistic antibacterial actions of graphene oxide and antibiotics towards bacteria and the toxicological effects of graphene oxide on human epidermal keratinocytes","volume":"142","author":"Pulingam","year":"2020","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.micpath.2026.108871_bib13","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/485439a","article-title":"Antibiotics: recover the lost art of drug discovery","volume":"485","author":"Lewis","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.micpath.2026.108871_bib14","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S1473-3099(19)30552-3","article-title":"(Inter)nationalising the antibiotic research and development pipeline","volume":"20","author":"Singer","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.micpath.2026.108871_bib15","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/S0140-6736(13)60604-2","article-title":"Annual Report of the Chief Medical Offi cer : infection and the rise of antimicrobial resistance","volume":"381","author":"Cleland","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.micpath.2026.108871_bib16","series-title":"Global Risks 2014","year":"2014"},{"key":"10.1016\/j.micpath.2026.108871_bib17","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1128\/CMR.00043-12","article-title":"Adaptive and mutational resistance : role of porins and efflux pumps","volume":"25","author":"Fern\u00e1ndez","year":"2012","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.micpath.2026.108871_bib18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1146\/annurev.biochem.78.082907.145923","article-title":"Multidrug resistance in bacteria","volume":"78","author":"Nikaido","year":"2009","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.micpath.2026.108871_bib19","first-page":"2629","article-title":"Permeation rates of penicillins indicate that Escherichia coli porins function principally as nonspeci fi c channels","author":"Kojima","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.micpath.2026.108871_bib20","first-page":"1","article-title":"Multidrug binding properties of the AcrB ef fl ux pump characterized by molecular dynamics simulations","author":"Vvargiu","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.micpath.2026.108871_bib21","first-page":"291","article-title":"The transloation Kinetics of antibiotics through porin OmpC: insights from structure-based solvation mapping using WaterMap","volume":"81","author":"Pearlstein","year":"2012","journal-title":"Proteins"},{"key":"10.1016\/j.micpath.2026.108871_bib22","doi-asserted-by":"crossref","first-page":"5406","DOI":"10.1128\/AAC.00580-10","article-title":"LmrS is a multidrug efflux pump of the major facilitator superfamily from Staphylococcus aureus","volume":"54","author":"Floyd","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2026.108871_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0051053","article-title":"An inducible fusaric acid tripartite efflux pump contributes to the fusaric acid resistance in stenotrophomonas maltophilia","volume":"7","author":"Hu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2026.108871_bib24","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/jac\/dks357","article-title":"Complete sequencing of an IncHI1 plasmid encoding the carbapenemase NDM-1, the ArmA 16S RNA methylase and a resistance\u2013nodulation\u2013cell division\/multidrug efflux pump","volume":"1407","author":"Dolejska","year":"2013","journal-title":"Jornel Antimicrob. Chemother."},{"key":"10.1016\/j.micpath.2026.108871_bib25","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1128\/AAC.00084-08","article-title":"ramR mutations involved in efflux-mediated multidrug resistance in Salmonella enterica serovar typhimurium","volume":"52","author":"Abouzeed","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2026.108871_bib26","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1128\/JB.01517-09","article-title":"RamA , a member of the AraC\/XylS family , influences both virulence and efflux in Salmonella enterica serovar typhimurium \u1c14","volume":"192","author":"Bailey","year":"2010","journal-title":"Journel Bacteriol."},{"key":"10.1016\/j.micpath.2026.108871_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms3078","article-title":"The crystal structure of multidrug-resistance regulator RamR with multiple drugs","volume":"4","author":"Yamasaki","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.micpath.2026.108871_bib28","doi-asserted-by":"crossref","first-page":"472","DOI":"10.2741\/1075","article-title":"ON the mechanism of solute uptake in PSEUDOMONAS","volume":"8","author":"Tamber","year":"2003","journal-title":"Front. Biosci."},{"key":"10.1016\/j.micpath.2026.108871_bib29","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ijantimicag.2012.08.010","article-title":"International Journal of Antimicrobial Agents Underlying mechanisms of carbapenem resistance in extended-spectrum \u2424 -lactamase-producing Klebsiella pneumoniae and Escherichia coli isolates at a tertiary care centre in Lebanon : role of OXA-48 and NDM-1 ca","volume":"41","author":"Baroud","year":"2013","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.micpath.2026.108871_bib30","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1128\/JCM.01244-13","article-title":"Outbreak caused by an ertapenem-resistant, CTX-M-15-producing","volume":"51","author":"Poulou","year":"2013","journal-title":"Journel Clin. Microbiol."},{"key":"10.1016\/j.micpath.2026.108871_bib31","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1128\/AAC.02005-12","article-title":"The target of daptomycin is absent from Escherichia coli and other gram-negative pathogens","volume":"57","author":"Randall","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2026.108871_bib32","first-page":"482","article-title":"Mechanisms of resistance to macrolides and lincosamides : nature of the resistance elements and their clinical implications","volume":"34","author":"Leclercq","year":"2002","journal-title":"Antimicrob. Esistance"},{"key":"10.1016\/j.micpath.2026.108871_bib33","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1128\/AAC.05760-11","article-title":"Novel penA mosaic allele in a successful international","volume":"56","author":"Unemo","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2026.108871_bib34","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1128\/AAC.44.6.1549-1555.2000","article-title":"A new class of genetic element , Staphylococcus cassette chromosome mec , encodes methicillin resistance in Staphylococcus aureus","volume":"44","author":"Katayama","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2026.108871_bib35","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S1473-3099(11)70126-8","article-title":"Meticillin-resistant Staphylococcus aureus with a novel mecA homologue in human and bovine populations in the UK and Denmark : a descriptive study","volume":"11","author":"Garc\u00eda-\u00e1lvarez","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.micpath.2026.108871_bib36","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1128\/AAC.01477-07","article-title":"Detection of methyltransferases conferring high-level resistance to aminoglycosides in enterobacteriaceae from Europe , North America , and Latin America","volume":"52","author":"Fritsche","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2026.108871_bib37","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1128\/CMR.05035-11","article-title":"Carbapenemases in Klebsiella pneumoniae and other enterobacteriaceae : an evolving crisis of global dimensions","volume":"25","author":"Daikos","year":"2012","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.micpath.2026.108871_bib38","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1128\/AAC.06142-11","article-title":"Diverse sequence types of Klebsiella pneumoniae contribute to the dissemination of bla NDM-1 in India , Sweden , and the United Kingdom","volume":"56","author":"Giske","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2026.108871_bib39","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.addr.2005.04.002","article-title":"Bacterial resistance to antibiotics : enzymatic degradation and modification","volume":"57","author":"Wright","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.micpath.2026.108871_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaim.2017.05.004","article-title":"Journal of ayurveda and integrative medicine development of botanicals to combat antibiotic resistance","volume":"8","author":"Gupta","year":"2017","journal-title":"J. Ayurveda Integr. Med."},{"key":"10.1016\/j.micpath.2026.108871_bib41","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S1473-3099(13)70318-9","article-title":"Antibiotic resistance \u2014 the need for global solutions","volume":"13","author":"Laxminarayan","year":"2013","journal-title":"Lancet Infect. Dis. Comm. Antibiot."},{"key":"10.1016\/j.micpath.2026.108871_bib42","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1128\/JB.00635-16","article-title":"Classic spotlight : the discovery of bacterial transduction","volume":"198","author":"Parkinson","year":"2016","journal-title":"Journel Bacteriol."},{"key":"10.1016\/j.micpath.2026.108871_bib43","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.3390\/genes11111239","article-title":"Plasmid transfer by conjugation in gram-negative bacteria : from the cellular to the community level","volume":"11","author":"Virolle","year":"2020","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.micpath.2026.108871_bib44","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00446-12","article-title":"Dueling regulatory properties of a transcriptional activator (MtrA) and repressor (MtrR) that control efflux pump gene expression in Neisseria gonorrhoeae","volume":"3","author":"Zalucki","year":"2012","journal-title":"MBio"},{"key":"10.1016\/j.micpath.2026.108871_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/595011","article-title":"Bad bugs , No drugs : No ESKAPE ! An update from the infectious diseases society of America","volume":"2111","author":"Boucher","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.micpath.2026.108871_bib46","first-page":"1","article-title":"Articles Discovery , research , and development of new antibiotics : the WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"3099","author":"Tacconelli","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.micpath.2026.108871_bib47","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1016\/j.jmb.2019.04.002","article-title":"\u03b2 -lactamases and \u03b2 -lactamase inhibitors in the 21st century","volume":"431","author":"Tooke","year":"2019","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.micpath.2026.108871_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.135253","article-title":"International Journal of Biological Macromolecules an escape from ESKAPE pathogens : a comprehensive review on current and emerging therapeutics against antibiotic resistance","volume":"279","author":"Singh","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.micpath.2026.108871_bib49","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3390\/bacteria3020006","article-title":"Eskape : navigating the global battlefield for antimicrobial resistance and defense in hospitals","volume":"3","author":"Ravi","year":"2024","journal-title":"Bacteria"},{"key":"10.1016\/j.micpath.2026.108871_bib50","first-page":"417","article-title":"Origins and evolution of antibiotic resistance, microbiol","volume":"74","author":"Davies","year":"2010","journal-title":"Mol. Biol."},{"key":"10.1016\/j.micpath.2026.108871_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1073\/pnas.1503141112","article-title":"Global trends in antimicrobial use in food animals","volume":"112","author":"Van Boeckel","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.micpath.2026.108871_bib52","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1863-2378.2007.01102.x","article-title":"Salmonella spp . in bavarian liquid pig manure : occurrence and relevance for the distribution of antibiotic resistance","volume":"55","author":"Bauer","year":"2008","journal-title":"Zoonoses Publ. Heal"},{"key":"10.1016\/j.micpath.2026.108871_bib53","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijfoodmicro.2013.04.003","article-title":"International Journal of Food Microbiology Occurrence of generic Escherichia coli , E . coli O157 and Salmonella spp . in water and sediment from leafy green produce farms and streams on the Central California coast","volume":"165","author":"Benjamin","year":"2013","journal-title":"Int. J. Food Microbiol."},{"key":"10.1016\/j.micpath.2026.108871_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcimb.2020.00497","article-title":"Epidemiological investigation and antimicrobial resistance profiles of Salmonella isolated from breeder chicken hatcheries in henan , China","volume":"10","author":"Xu","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.micpath.2026.108871_bib55","series-title":"Chapter 7 - Antimicrobial Resistant Genes and Organisms as Environmental Contaminants of Emerging Concern: Addressing Global Public Health Risks","author":"Sanderson","year":"2019"},{"key":"10.1016\/j.micpath.2026.108871_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijheh.2022.114006","article-title":"International Journal of Hygiene and Environmental Health Prevalence of ESKAPE pathogens in the environment : antibiotic resistance status , community-acquired infection and risk to human health","volume":"244","author":"Denissen","year":"2022","journal-title":"Int. J. Hyg Environ. Health"},{"key":"10.1016\/j.micpath.2026.108871_bib57","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.2147\/IDR.S471645","article-title":"ESKAPE pathogens : antimicrobial resistance patterns , risk factors , and outcomes a retrospective cross-sectional study of hospitalized patients in Palestine","volume":"17","author":"Abukhalil","year":"2024","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.micpath.2026.108871_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0034953","article-title":"Antibiotic resistance is prevalent in an isolated cave microbiome","volume":"7","author":"Bhullar","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2026.108871_bib59","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1939-1676.2005.tb02739.x","article-title":"ACVIM consensus statement,","volume":"19","author":"Morley","year":"2005","journal-title":"J. Vet. Int. Med."},{"key":"10.1016\/j.micpath.2026.108871_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.tim.2006.02.006","article-title":"Co-selection of antibiotic and metal resistance","volume":"14","author":"Baker-austin","year":"2006","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.micpath.2026.108871_bib61","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.watres.2016.02.049","article-title":"Co-occurrence of integrase 1 , antibiotic and heavy metal resistance genes in municipal wastewater treatment plants","volume":"94","author":"Di","year":"2016","journal-title":"Water Res."},{"key":"10.1016\/j.micpath.2026.108871_bib62","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.envint.2015.10.015","article-title":"Concentrations of antibiotics predicted to select for resistant bacteria : proposed limits for environmental regulation","volume":"86","author":"Bengtsson-palme","year":"2016","journal-title":"Environ. Int."},{"key":"10.1016\/j.micpath.2026.108871_bib63","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.envint.2018.06.004","article-title":"Non-antibiotic antimicrobial triclosan induces multiple antibiotic resistance through genetic mutation","volume":"118","author":"Lu","year":"2018","journal-title":"Environ. Int."},{"key":"10.1016\/j.micpath.2026.108871_bib64","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.928509","article-title":"Prevalence of antimicrobial resistance in select bacteria from retail seafood \u2014 United States , 2019","volume":"13","author":"Tate","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2026.108871_bib65","first-page":"1","article-title":"The rising tide of antimicrobial resistance in aquaculture : sources , sinks and solutions","volume":"158","author":"Watts","year":"2017","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.micpath.2026.108871_bib66","first-page":"9237","article-title":"The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans , animals and food in 2022 \u2013 2023","volume":"23","author":"Report","year":"2025","journal-title":"Efsa J."},{"key":"10.1016\/j.micpath.2026.108871_bib67","first-page":"1","article-title":"Foodborne antimicrobial resistance as a biological hazard draft scientific opinion of the panel on biological hazards draft endorsed on 6 march 2008","volume":"765","author":"Andreoletti","year":"2008","journal-title":"EFSA Journel"},{"key":"10.1016\/j.micpath.2026.108871_bib68","first-page":"3025","article-title":"Scientific Opinion on the risk posed by pathogens in food of non-animal origin . Part 1 (outbreak data analysis and risk ranking of food\/pathogen","volume":"11","author":"Opinion","year":"2013","journal-title":"EFSA Journel"},{"key":"10.1016\/j.micpath.2026.108871_bib69","first-page":"1","article-title":"Annals of animal science","volume":"22","author":"Chmielowiec-korzeniowska","year":"2021","journal-title":"Ann. Anim. Sci."},{"key":"10.1016\/j.micpath.2026.108871_bib70","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1574-6941.1999.tb00629.x","article-title":"Microbial air pollution caused by intensive broiler chicken breeding","volume":"29","author":"Baykov","year":"1999","journal-title":"FEMS Microbiol. Ecol."},{"key":"10.1016\/j.micpath.2026.108871_bib71","first-page":"37","article-title":"Journal of occupational and environmental hygiene","volume":"1","author":"Taylor","year":"2004","journal-title":"J. OfOccupational Environ. Hyg."},{"key":"10.1016\/j.micpath.2026.108871_bib72","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.prevetmed.2011.06.005","article-title":"Prevalence and risk factor analysis of livestock associated MRSA-positive pig herds in The Netherlands","volume":"102","author":"Broens","year":"2011","journal-title":"Prev. Vet. Med."},{"key":"10.1016\/j.micpath.2026.108871_bib73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2012.00018","article-title":"Origin and evolution of antibiotic resistance : the common mechanisms of emergence and spread in water bodies","volume":"3","author":"Lupo","year":"2012","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2026.108871_bib74","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.copbio.2008.05.006","article-title":"Antibiotics and antibiotic resistance in water environments","volume":"19","author":"Canto","year":"2008","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.micpath.2026.108871_bib75","first-page":"633","article-title":"The role of drinking water in the transmission of antimicrobial-resistant","volume":"140","author":"Ie","year":"2012","journal-title":"E . coli"},{"key":"10.1016\/j.micpath.2026.108871_bib76","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1089\/dna.2019.4874","article-title":"Interactions of designed Trp-containing antimicrobial","volume":"40","author":"Han","year":"2020","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.micpath.2026.108871_bib77","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.3390\/ijms22041522","article-title":"Thanatin : an emerging host defense antimicrobial peptide with multiple modes of action","volume":"22","author":"Dash","year":"2021","journal-title":"Int. Journel Mol. Sci."},{"key":"10.1016\/j.micpath.2026.108871_bib78","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.intimp.2018.10.030","article-title":"International Immunopharmacology Pretreatment with cathelicidin-BF ameliorates Pseudomonas aeruginosa pneumonia in mice by enhancing NETosis and the autophagy of recruited neutrophils and macrophages","volume":"65","author":"Liu","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.micpath.2026.108871_bib79","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s10493-020-00584-1","article-title":"A novel defensin-like peptide contributing to antimicrobial and antioxidant capacity of the tick Dermacentor silvarum (Acari","volume":"83","author":"Li","year":"2021","journal-title":"Exp. Appl. Acarol."},{"key":"10.1016\/j.micpath.2026.108871_bib80","doi-asserted-by":"crossref","first-page":"4578","DOI":"10.3390\/ijms21134578","article-title":"Antimicrobial peptides display strong synergy with vancomycin against vancomycin-resistant","volume":"21","author":"Wild-type","year":"2020","journal-title":"Int. Journel Mol. Sci."},{"key":"10.1016\/j.micpath.2026.108871_bib81","first-page":"1","article-title":"Peptide-mimicking poly (2-oxazoline) s displaying potent antimicrobial properties","volume":"16","author":"Zhou","year":"2020","journal-title":"ChemMedChem"},{"key":"10.1016\/j.micpath.2026.108871_bib82","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1126\/scitranslmed.aan4044","article-title":"The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms","volume":"10","author":"De Breij","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.micpath.2026.108871_bib83","doi-asserted-by":"crossref","first-page":"27620","DOI":"10.1073\/pnas.2007036117","article-title":"Defining principles that influence antimicrobial peptide activity against capsulated Klebsiella pneumoniae","volume":"117","author":"Fleeman","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.micpath.2026.108871_bib84","first-page":"1","article-title":"Revealing the mechanisms of synergistic action of two magainin antimicrobial peptides","volume":"2","author":"Bechinger","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2026.108871_bib85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1073\/pnas.1909585117","article-title":"The antimicrobial peptide ZY4 combats multidrug- resistant Pseudomonas aeruginosa and Acinetobacter baumannii infection","volume":"116","author":"Mwangi","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.micpath.2026.108871_bib86","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1089\/dna.2007.0693","article-title":"The synthetic antimicrobial peptide KLKL 5 KLK enhances the protection and efficacy of the combined DNA vaccine against Mycobacterium tuberculosis","volume":"27","author":"Li","year":"2008","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.micpath.2026.108871_bib87","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.peptides.2012.05.006","article-title":"The antimicrobial activity of the appetite peptide hormone ghrelin","volume":"36","author":"Min","year":"2012","journal-title":"Peptides"},{"key":"10.1016\/j.micpath.2026.108871_bib88","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.616979","article-title":"Review : lessons learned from clinical trials using antimicrobial peptides (AMPs)","volume":"12","author":"Dijksteel","year":"2021","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2026.108871_bib89","first-page":"6038","article-title":"The antimicrobial peptides : ready for clinical trials","volume":"7","author":"Ab","year":"2018","journal-title":"Journel Sci. Tech. Res."},{"key":"10.1016\/j.micpath.2026.108871_bib90","doi-asserted-by":"crossref","first-page":"9050","DOI":"10.1021\/acs.jmedchem.2c00270","article-title":"Antimicrobial peptides against multidrug-resistant Pseudomonas aeruginosa bio fi lm from cystic fibrosis patients","volume":"65","author":"Ben Hur","year":"2022","journal-title":"Journel Med. Chem."},{"key":"10.1016\/j.micpath.2026.108871_bib91","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1128\/AAC.01516-10","article-title":"Antimicrobial peptoids are effective against Pseudomonas aeruginosa biofilms","volume":"55","author":"Kapoor","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2026.108871_bib92","article-title":"Current Research in Microbial Sciences Assessment of the efficacy of an antimicrobial peptide in the context of cystic fibrosis airways","volume":"8","author":"Jouault","year":"2025","journal-title":"Curr. Res. Microb. Sci."},{"key":"10.1016\/j.micpath.2026.108871_bib93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2017.02659","article-title":"Phage therapy as a promising new treatment for lung infection caused by carbapenem-resistant acinetobacter baumannii in mice","volume":"8","author":"Hua","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2026.108871_bib94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ofid\/ofy064","article-title":"Phage therapy for a multidrug- resistant acinetobacter baumannii craniectomy site infection","volume":"5","author":"Lavergne","year":"2018","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.micpath.2026.108871_bib95","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.coviro.2021.11.001","article-title":"Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID- 19 . The COVID-19 resource centre is hosted on Elsevier Connect , the company \u2019 s public news and information","volume":"52","author":"Wu","year":"2020","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.micpath.2026.108871_bib96","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcimb.2021.631585","article-title":"Clinical experience of personalized phage therapy against carbapenem- resistant acinetobacter baumannii lung infection in a patient with chronic obstructive pulmonary disease","volume":"11","author":"Tan","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.micpath.2026.108871_bib97","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3390\/antibiotics10030281","article-title":"Baumannii in the pathogenesis of urinary tract infection and the potential of its treatment with the use of bacteriophage therapy","volume":"10","author":"Baginska","year":"2021","journal-title":"Antibiotics"},{"key":"10.1016\/j.micpath.2026.108871_bib98","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1473-3099(18)30482-1","article-title":"Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised , controlled , double-blind","volume":"19","author":"Jault","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.micpath.2026.108871_bib99","first-page":"158","article-title":"Bacteriophage therapy for empyema caused by carbapenem- resistant Pseudomonas aeruginosa","volume":"16","author":"Chen","year":"2022","journal-title":"Case Rep."},{"key":"10.1016\/j.micpath.2026.108871_bib100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2018.02127","article-title":"Bacteriophage ZCKP1 : a potential treatment for Klebsiella pneumoniae isolated from diabetic foot patients bacterial strains and growth media","volume":"9","author":"Taha","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2026.108871_bib101","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1038\/s41467-022-31837-9","article-title":"Personalized bacteriophage therapy to treat pandrug-resistant spinal Pseudomonas aeruginosa infection","volume":"13","author":"Gustave","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.micpath.2026.108871_bib102","first-page":"66","article-title":"Personalized infectious disease medicine for the most vulnerable at-risk patients","volume":"1","author":"Terwilliger","year":"2020","journal-title":"Phage"},{"key":"10.1016\/j.micpath.2026.108871_bib103","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1093\/cid\/ciad335","article-title":"A retrospective , observational study of 12 cases of expanded-access customized phage therapy : production , characteristics , and clinical outcomes","volume":"77","author":"Green","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.micpath.2026.108871_bib104","first-page":"1","article-title":"Application of phage therapy in a case of a chronic hip- prosthetic joint infection due to Pseudomonas aeruginosa : an Italian real-life experience and in vitro analysis","volume":"10","author":"Cesta","year":"2016","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.micpath.2026.108871_bib105","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.clinthera.2023.06.009","article-title":"Phage therapy for diabetic foot infection : a case series","volume":"45","author":"Young","year":"2023","journal-title":"Clin. Ther."},{"key":"10.1016\/j.micpath.2026.108871_bib106","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01728-23","article-title":"Pseudomonas aeruginosa ventricular assist device infections: findings from ineffective phage therapies in five cases","volume":"68","author":"Aslam","year":"2024","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2026.108871_bib107","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/iai.00176-22","article-title":"Human monoclonal antibodies to Escherichia coli outer membrane protein A porin domain cause aggregation but do not alter in vivo bacterial burdens in a murine sepsis model","volume":"90","author":"Fowler","year":"2022","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2026.108871_bib108","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3390\/antibiotics9040155","article-title":"Monoclonal antibodies as an antibacterial approach against bacterial pathogens","volume":"9","author":"Vzurawski","year":"2020","journal-title":"Antibiotics"},{"key":"10.1016\/j.micpath.2026.108871_bib109","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nature16057","article-title":"Novel antibody\u2013antibiotic conjugate eliminates intracellular S. aureus","volume":"527","author":"Lehar","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.micpath.2026.108871_bib110","doi-asserted-by":"crossref","first-page":"629.e1","DOI":"10.1016\/j.cmi.2018.08.004","article-title":"Phase 1 study of MEDI3902 , an investigational anti e Pseudomonas aeruginosa PcrV and Psl bispeci fi c human monoclonal antibody , in healthy adults","volume":"25","author":"Ali","year":"2018","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.micpath.2026.108871_bib111","first-page":"484","article-title":"KB001-A , a novel anti-in fl ammatory , found to be safe and well-tolerated in cystic fi brosis patients infected with Pseudomonas aeruginosa","volume":"17","author":"Chmiel","year":"2017","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.micpath.2026.108871_bib112","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1080\/21505594.2016.1231295","article-title":"Monoclonal antibodies protect from Staphylococcal Enterotoxin K (SEK) induced toxic shock and sepsis by USA300 Staphylococcus aureus","volume":"8","author":"Aguilar","year":"2017","journal-title":"Virulance"},{"key":"10.1016\/j.micpath.2026.108871_bib113","article-title":"Anti-Ace monoclonal antibody reduces Enterococcus faecalis aortic valve infection in a rat infective endocarditis model","volume":"76","author":"Vsingh","year":"2018","journal-title":"Pathog. Dis."},{"key":"10.1016\/j.micpath.2026.108871_bib114","doi-asserted-by":"crossref","first-page":"4526","DOI":"10.1128\/AAC.00510-15","article-title":"MEDI4893 * promotes survival and extends the antibiotic treatment window in a Staphylococcus aureus immunocompromised pneumonia","volume":"59","author":"Hua","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2026.108871_bib115","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00710-19","article-title":"Treatment efficacy of MEDI3902 in pseudomonas aeruginosa bloodstream infection and acute pneumonia rabbit models","volume":"63","author":"Le","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2026.108871_bib116","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02220-19","article-title":"Protective efficacy of monoclonal antibodies neutralizing alpha-hemolysin and bicomponent leukocidins in a rabbit model of Staphylococcus aureus necrotizing pneumonia","volume":"64","author":"Vu","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2026.108871_bib117","series-title":"Enzybiotics : Endolysins and Bacteriocins","author":"Heselpoth","year":"2018"},{"key":"10.1016\/j.micpath.2026.108871_bib118","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2025.1603380","article-title":"Endolysins and membrane-active peptides : innovative engineering strategies against gram-negative bacteria","volume":"16","author":"Wojciechowska","year":"2025","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2026.108871_bib119","first-page":"3750","volume":"vol. 130","author":"Jr","year":"2020"},{"key":"10.1016\/j.micpath.2026.108871_bib120","article-title":"Crossm pharmacokinetics and tolerance of the phage endolysin-based candidate drug SAL200 after a single intravenous administration among healthy","volume":"61","author":"Drug","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2026.108871_bib121","article-title":"PlyKp104 , a novel phage lysin for the treatment of Klebsiella","volume":"67","author":"EulerW","year":"2023","journal-title":"Antimicrob. Agents Chemo"},{"key":"10.1016\/j.micpath.2026.108871_bib122","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0899-9007(02)00811-0","article-title":"Early enteral supply of fiber and lactobacilli versus conventional nutrition : a controlled trial in patients with major abdominal surgery","volume":"18","author":"Rayes","year":"2002","journal-title":"Nutrition"},{"key":"10.1016\/j.micpath.2026.108871_bib123","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s00423-004-0536-1","article-title":"Synbiotics reduce postoperative infectious complications : a randomized controlled trial in biliary cancer patients undergoing hepatectomy","volume":"390","author":"Kanazawa","year":"2005","journal-title":"Langenbecks Arch. Surg."},{"key":"10.1016\/j.micpath.2026.108871_bib124","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1600-6143.2004.00649.x","article-title":"Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation \u2014 a randomized , double-blind trial","volume":"5","author":"Munksgaard","year":"2005","journal-title":"Am. J. OfTransplantation"},{"key":"10.1016\/j.micpath.2026.108871_bib125","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/01.sla.0000259442.78947.19","article-title":"Effect of enteral nutrition and synbiotics on bacterial infection rates after pylorus-preserving pancreatoduodenectomy","volume":"246","author":"Randomized","year":"2007","journal-title":"Ann. Surg."},{"key":"10.1016\/j.micpath.2026.108871_bib126","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1469-0691.2009.02793.x","article-title":"Interleukin-8 production by polymorphonuclear leukocytes from patients with chronic infected leg ulcers treated with Lactobacillus plantarum","volume":"16","author":"Peral","year":"2009","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.micpath.2026.108871_bib127","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1365-2036.2010.04492.x","article-title":"Alimentary Pharmacology and Therapeutics Randomised clinical trial : the effects of perioperative probiotic treatment on barrier function and post-operative infectious complications in colorectal cancer surgery \u2013 a double-blind study","volume":"33","author":"Liu","year":"2010","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.micpath.2026.108871_bib128","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1177\/0148607110379813","article-title":"Effects of perioperative synbiotic treatment on infectious complications , intestinal integrity , and fecal flora and organic acids in hepatic surgery with or without cirrhosis","volume":"35","author":"Usami","year":"2011","journal-title":"J. Parenter. Enteral Nutr."},{"key":"10.1016\/j.micpath.2026.108871_bib129","first-page":"199","article-title":"Preoperative probiotics decrease postoperative infectious complications of colorectal cancer","volume":"343","author":"Zhang","year":"2012","journal-title":"Med. Sci."},{"key":"10.1016\/j.micpath.2026.108871_bib130","first-page":"142","article-title":"Probiotic use in preventing postoperative infection in liver transplant patients","volume":"2","author":"Zhang","year":"2013","journal-title":"Hepatobiliary Surg. Nutr."},{"key":"10.1016\/j.micpath.2026.108871_bib131","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.surg.2013.06.002","article-title":"Comparison between oral antibiotics and probiotics as bowel preparation for elective colon cancer surgery to prevent infection : prospective randomized trial","volume":"155","author":"Sadahiro","year":"2014","journal-title":"Surgery"},{"key":"10.1016\/j.micpath.2026.108871_bib132","doi-asserted-by":"crossref","first-page":"966","DOI":"10.3892\/etm.2015.2640","article-title":"Impact of perioperative probiotic treatment for surgical site infections in patients with colorectal cancer","volume":"10","author":"Aisu","year":"2015","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.micpath.2026.108871_bib133","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2013.08.003","article-title":"Role of probiotics in the prevention and treatment of meticillin-resistant Staphylococcus aureus infections","author":"Sikorska","year":"2013","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.micpath.2026.108871_bib134","first-page":"39","article-title":"Impact of Probiotics for Reducing Infections in Veterans (IMPROVE): study protocol for a double-blind, randomized controlled trial to reduce carriage of Staphylococcus aureus","volume":"52","author":"Hess","year":"2016","journal-title":"Contemp. Clin. Trials"},{"key":"10.1016\/j.micpath.2026.108871_bib135","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/apt.13144","article-title":"Alimentary Pharmacology and Therapeutics Randomised clinical trial : faecal microbiota transplantation by colonoscopy vs . vancomycin for the treatment of recurrent Clostridium dif fi cile infection","volume":"41","author":"Dinoi","year":"2015","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.micpath.2026.108871_bib136","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1001\/jama.2017.17077","article-title":"Effect of oral capsule\u2013 vs colonoscopy-delivered fecal microbiota transplantation on recurrent","volume":"318","author":"Rioux","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.micpath.2026.108871_bib137","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1001\/jama.2015.18098","article-title":"Frozen vs fresh fecal microbiota transplantation and clinical resolution of diarrhea in patients with recurrent Clostridium difficile infection A randomized clinical trial","volume":"315","author":"Lee","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.micpath.2026.108871_bib138","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/cid\/cix762","article-title":"Early fecal microbiota transplantation improves survival in severe Clostridium difficile infections","volume":"66","author":"Hocquart","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.micpath.2026.108871_bib139","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1093\/cid\/civ938","article-title":"Safety and durability of RBX2660 (microbiota suspension) for recurrent Clostridium difficile infection: results of the PUNCH CD study","volume":"62","author":"Orenstein","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.micpath.2026.108871_bib140","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1093\/cid\/cix252","article-title":"Fecal microbiota transplantation in patients with blood disorders inhibits gut colonization with antibiotic-resistant bacteria : results of a prospective , single-center study","volume":"65","author":"Bilinski","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.micpath.2026.108871_bib141","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jhin.2017.02.001","article-title":"Is faecal microbiota transplantation an option to eradicate highly drug-resistant enteric bacteria carriage","volume":"95","author":"Davido","year":"2017","journal-title":"J. Hosp. Infect."},{"key":"10.1016\/j.micpath.2026.108871_bib142","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.jhin.2018.02.018","article-title":"Clearance of Carbapenem-resistant Enterobacteriaceae versus Vancomycin-resistant enterococci carriage after fecal microbiota transplant: a prospective comparative study","volume":"99","author":"Dinh","year":"2018","journal-title":"J. Hosp. Infect."},{"key":"10.1016\/j.micpath.2026.108871_bib143","first-page":"4","article-title":"Fecal microbiota transplantation against intestinal colonization by extended spectrum beta - lactamase producing Enterobacteriaceae : a proof of principle study","author":"Singh","year":"2018","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.micpath.2026.108871_bib144","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/s12879-015-0973-1","article-title":"Fecal microbiota transplantation restores dysbiosis in patients with methicillin resistant Staphylococcus aureus enterocolitis","volume":"15","author":"Wei","year":"2015","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.micpath.2026.108871_bib145","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.3390\/biomedicines10102404","article-title":"Efficacy and safety of fecal microbiota transplantation for clearance of multidrug-resistant organisms under multiple comorbidities : a prospective comparative trial","volume":"10","author":"Shin","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.micpath.2026.108871_bib146","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.2147\/IDR.S308308","article-title":"Fecal microbiota transplantation as an effective treatment for carbapenem-resistant Klebsiella pneumoniae infection in a renal transplant patient","volume":"14","author":"Wang","year":"2021","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.micpath.2026.108871_bib147","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s40001-021-00508-8","article-title":"Tandem fecal microbiota transplantation cycles in an allogeneic hematopoietic stem cell transplant recipient targeting carbapenem - resistant Enterobacteriaceae colonization : a case report and literature review","volume":"26","author":"Res","year":"2021","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.micpath.2026.108871_bib148","doi-asserted-by":"crossref","first-page":"925","DOI":"10.17235\/reed.2020.7150\/2020","article-title":"Fecal microbiota transplantation in the intestinal decolonization of carbapenamase-producing enterobacteriaceae","volume":"112","author":"Silva","year":"2020","journal-title":"Rev. Esp. Enferm. Dig."},{"key":"10.1016\/j.micpath.2026.108871_bib149","first-page":"e166","article-title":"Oral capsulized Fecal microbiota transplantation for eradication of carbapenemase-producing Enterobacteriaceae colonization with a metagenomic perspective","volume":"73","author":"Chowers","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.micpath.2026.108871_bib150","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.cmi.2018.12.009","article-title":"A 5-day course of oral antibiotics followed by faecal transplantation to eradicate carriage of multidrug-resistant Enterobacteriaceae : a randomized clinical trial","volume":"25","author":"Huttner","year":"2019","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.micpath.2026.108871_bib151","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1155\/2019\/2015978","article-title":"Quorum sensing : a prospective therapeutic target for bacterial diseases","volume":"2019","author":"Jiang","year":"2019","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.micpath.2026.108871_bib152","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.3390\/molecules29153466","article-title":"Quorum sensing inhibitors : an alternative strategy to win","volume":"29","author":"Mdr","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.micpath.2026.108871_bib153","first-page":"3","article-title":"Non-antibiotic management for Clostridium difficile infection","volume":"6","author":"Sood","year":"2016","journal-title":"Journel Gastrointest. Infect."},{"key":"10.1016\/j.micpath.2026.108871_bib154","doi-asserted-by":"crossref","first-page":"262","DOI":"10.18683\/germs.2022.1328","article-title":"Anti-virulence therapeutic strategies against bacterial infections : recent advances","volume":"12","author":"Dehbanipour","year":"2022","journal-title":"Germs"},{"key":"10.1016\/j.micpath.2026.108871_bib155","first-page":"1283","article-title":"CRISPR-Cas-Based antimicrobials: design, challenges, and bacterial mechanisms of resistance","volume":"9","author":"Carrera-pacheco","year":"2023","journal-title":"Infect. Dis. (Auckl)"},{"key":"10.1016\/j.micpath.2026.108871_bib156","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.3390\/antibiotics13121141","article-title":"Current knowledge on CRISPR strategies against antimicrobial-resistant bacteria","volume":"13","author":"De","year":"2024","journal-title":"Antibiotics"},{"key":"10.1016\/j.micpath.2026.108871_bib157","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcimb.2024.1408569","article-title":"Beyond antibiotics : CRISPR\/Cas9 triumph over bio fi lm-associated antibiotic resistance infections","volume":"14","author":"Zuberi","year":"2024","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.micpath.2026.108871_bib158","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3390\/antibiotics14020207","article-title":"Nanomaterial-based strategies to combat antibiotic resistance: mechanisms and applications","volume":"14","author":"Parvin","year":"2025","journal-title":"Antibiotics"},{"key":"10.1016\/j.micpath.2026.108871_bib159","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3390\/pharmaceutics18020185","article-title":"Nano-enabled delivery of phage-based antibacterials against ESKAPE pathogens","volume":"18","author":"Elbehiry","year":"2026","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.micpath.2026.108871_bib160","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1038\/nbt.3043","article-title":"Development of sequence-specific antimicrobials based on programmable CRISPR-Cas nucleases","volume":"32","author":"Bikard","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.micpath.2026.108871_bib161","first-page":"1141","article-title":"Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases","volume":"32","author":"Sierra","year":"2015","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.micpath.2026.108871_bib162","doi-asserted-by":"crossref","first-page":"7267","DOI":"10.1073\/pnas.1500107112","article-title":"Temperate and lytic bacteriophages programmed to sensitize and kill antibiotic-resistant bacteria","volume":"112","author":"Yosef","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.micpath.2026.108871_bib163","doi-asserted-by":"crossref","first-page":"10757","DOI":"10.1021\/acsomega.3c00312","article-title":"Antibiotic adjuvants : a versatile approach to combat antibiotic resistance","volume":"8","author":"Dhanda","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.micpath.2026.108871_bib164","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060666","article-title":"The efflux inhibitor phenylalanine-arginine beta- naphthylamide (PA b N) permeabilizes the outer membrane of gram-negative bacteria","volume":"8","author":"Lamers","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2026.108871_bib165","doi-asserted-by":"crossref","first-page":"8665","DOI":"10.1021\/acs.jmedchem.8b01781","article-title":"Antibiotic adjuvants : make antibiotics great again ! Antibiotic adjuvants : make antibiotics great again","volume":"62","author":"Andrieu","year":"2019","journal-title":"Jounal Med. Chem."},{"key":"10.1016\/j.micpath.2026.108871_bib166","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00883-17","article-title":"Ceftazidime-avibactam is superior to other treatment regimens against","volume":"61","author":"Shields","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2026.108871_bib167","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2147\/IDR.S445243","article-title":"Clinical outcomes and risk factors for death in critically ill patients with carbapenem-resistant Klebsiella pneumoniae treated with ceftazidime-avibactam: a retrospective study","volume":"17","author":"Zhang","year":"2024","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.micpath.2026.108871_bib168","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1093\/cid\/ciz530","article-title":"RESTORE-IMI 1: a multicenter, randomized, doubleblind trial comparing efficacy and safety of imipenem\/relebactam vs colistin plus imipenem in patients with imipenem-nonsusceptible bacterial infections","volume":"70","author":"Motsch","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.micpath.2026.108871_bib169","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.cmi.2024.11.006","article-title":"Aztreonam and avibactam combination therapy for metallo- b - lactamase-producing gram-negative bacteria : a Narrative Review","volume":"31","author":"Sangiorgio","year":"2025","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.micpath.2026.108871_bib170","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.3390\/pharmaceutics15112582","article-title":"Nanotechnology-based drug delivery systems to control bacterial-biofilm-associated lung infections","volume":"15","author":"Guo","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.micpath.2026.108871_bib171","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3390\/ijms18010120","article-title":"The role of reactive oxygen species (ROS) in the biological activities of metallic nanoparticles","volume":"18","author":"Dayem","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micpath.2026.108871_bib172","first-page":"818","article-title":"Phase II studies of nebulised Arikace in CF patients with Pseudomonas aeruginosa infection","volume":"68","author":"Clancy","year":"2013","journal-title":"Clin. Trials"},{"key":"10.1016\/j.micpath.2026.108871_bib173","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1574-6968.2007.00996.x","article-title":"Isolation and characterization of a novel Enterococcus faecalis bacteriophage\/EF24C as a therapeutic candidate","volume":"278","author":"Uchiyama","year":"2008","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.micpath.2026.108871_bib174","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2018.02517","article-title":"Phage-borne depolymerases decrease Klebsiella pneumoniae resistance to innate defense mechanisms","volume":"9","author":"Majkowska-skrobek","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2026.108871_bib175","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaa389","article-title":"Lessons learned from the first 10 consecutive cases of intravenous bacteriophage therapy to treat multidrug- resistant bacterial infections at a single center in the United States","volume":"7","author":"Aslam","year":"2020","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.micpath.2026.108871_bib176","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4236\/jbnb.2010.11005","article-title":"Effect of nano - titanium dioxide with different antibiotics against methicillin-resistant Staphylococcus aureus","volume":"2010","author":"Roy","year":"2010","journal-title":"J. Biomaterials Nanobiotechnol."},{"key":"10.1016\/j.micpath.2026.108871_bib177","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1128\/AEM.06513-11","article-title":"Nanoparticles functionalized with ampicillin destroy multiple- antibiotic-resistant isolates of Pseudomonas aeruginosa and Enterobacter aerogenes and methicillin-resistant Staphylococcus aureus","author":"Brown","year":"2012","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.micpath.2026.108871_bib178","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.colsurfb.2015.02.009","article-title":"Synthesis and antimicrobial activity of monodisperse copper nanoparticles","volume":"128","author":"Piotr","year":"2015","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.micpath.2026.108871_bib179","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ijantimicag.2019.05.019","article-title":"Antimicrobial activity of two novel antimicrobial peptides AA139 and SET-M33 against clinically and genotypically diverse Klebsiella pneumoniae isolates with differing antibiotic resistance profiles","volume":"54","author":"van der Weide","year":"2019","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.micpath.2026.108871_bib180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/antibiotics14070699","article-title":"Antimicrobial peptides SET-M33L and SET-M33L-PEG are promising agents against strong biofilm-forming P. aeruginosa, including multidrug-resistant isolates","volume":"14","author":"Fontanot","year":"2025","journal-title":"Antibiotics"},{"key":"10.1016\/j.micpath.2026.108871_bib181","article-title":"Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated","volume":"61","author":"Acinetobacter","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2026.108871_bib182","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2018.01832","article-title":"Adapted bacteriophages for treating urinary tract infections","volume":"9","author":"Ujmajuridze","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2026.108871_bib183","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jcf.2017.12.006","article-title":"KB001-A, a novel anti-inflammatory, found to be safe and well-tolerated in cystic fibrosis patients infected with Pseudomonas aeruginosa","volume":"17","author":"Jain","year":"2018","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.micpath.2026.108871_bib184","doi-asserted-by":"crossref","first-page":"629.e1","DOI":"10.1016\/j.cmi.2018.08.004","article-title":"Phase 1 study of MEDI3902, an investigational anti\u2013Pseudomonas aeruginosa PcrV and Psl bispecific human monoclonal antibody, in healthy adults","volume":"25","author":"Ali","year":"2019","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.micpath.2026.108871_bib185","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1128\/AAC.02190-13","article-title":"Assessment of an anti-alpha-toxin monoclonal antibody for prevention and treatment of Staphylococcus aureus-induced pneumonia","volume":"58","author":"Hua","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2026.108871_bib186","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00731-18","article-title":"Effects of phage endolysin SAL200 combined with antibiotics on staphylococcus aureus infection","volume":"62","author":"Kim","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2026.108871_bib187","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-00005-6","article-title":"Biofilm inhibition of multidrug-resistant Pseudomonas aeruginosa using green-synthesized silver nanoparticles and colistin","volume":"15","author":"Azimzadeh","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2026.108871_bib188","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2021.111965","article-title":"Synthesis of silver-nisin nanoparticles with low cytotoxicity as antimicrobials against biofilm-forming pathogens","volume":"206","author":"Zhao","year":"2021","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.micpath.2026.108871_bib189","doi-asserted-by":"crossref","first-page":"7934","DOI":"10.1021\/acsnano.6b03862","article-title":"Antimicrobial cluster bombs: silver nanoclusters packed with daptomycin","volume":"10","author":"Zheng","year":"2016","journal-title":"ACS Nano"},{"key":"10.1016\/j.micpath.2026.108871_bib190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5812\/jjm.27997","article-title":"Synergistic antibacterial activity of plant peptide MBP-1 and silver nanoparticles combination on healing of infected wound due to staphylococcus aureus","volume":"9","author":"Salouti","year":"2016","journal-title":"Jundishapur J. Microbiol."},{"key":"10.1016\/j.micpath.2026.108871_bib191","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1038\/s41591-025-03678-8","article-title":"Personalized inhaled bacteriophage therapy for treatment of multidrug-resistant Pseudomonas aeruginosa in cystic fibrosis","volume":"31","author":"Chan","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.micpath.2026.108871_bib192","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00037-23","article-title":"Therapeutic potential of intravenous phage as standalone therapy for recurrent drug-resistant urinary tract infections","volume":"67","author":"Le","year":"2023","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2026.108871_bib193","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1038\/s41467-020-16731-6","article-title":"Development of CRISPR-Cas13a-based antimicrobials capable of sequence-specific killing of target bacteria","volume":"11","author":"Kiga","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.micpath.2026.108871_bib194","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41429-024-00731-5","article-title":"Miconazole and phenothiazine hinder the quorum sensing regulated virulence in Pseudomonas aeruginosa","volume":"77","author":"Gad","year":"2024","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.micpath.2026.108871_bib195","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.3390\/biology11101466","article-title":"Quorum sensing in ESKAPE bugs: a target for combating antimicrobial resistance and bacterial virulence","volume":"11","author":"Santajit","year":"2022","journal-title":"Biology"},{"key":"10.1016\/j.micpath.2026.108871_bib196","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13073-024-01306-7","article-title":"Long-term beneficial effect of faecal microbiota transplantation on colonisation of multidrug-resistant bacteria and resistome abundance in patients with recurrent Clostridioides difficile infection","volume":"16","author":"Nooij","year":"2024","journal-title":"Genome Med."},{"key":"10.1016\/j.micpath.2026.108871_bib197","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1001\/jama.2015.18098","article-title":"Frozen vs fresh fecal microbiota transplantation and clinical resolution of diarrhea in patients with recurrent clostridium difficile infection a randomized clinical trial","volume":"15","author":"Lee","year":"2016","journal-title":"JAMA, J. Am. Med. Assoc."},{"key":"10.1016\/j.micpath.2026.108871_bib198","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1056\/NEJMoa1205037","article-title":"Duodenal infusion of donor feces for recurrent Clostridium difficile","volume":"368","author":"van Nood","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.micpath.2026.108871_bib199","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/cc6907","article-title":"Oral probiotic and prevention of Pseudomonas aeruginosa infections: a randomized, double-blind, placebo-controlled pilot study in intensive care unit patients","volume":"12","author":"Forestier","year":"2008","journal-title":"Crit. Care"},{"key":"10.1016\/j.micpath.2026.108871_bib200","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/s41586-018-0616-y","article-title":"Pathogen elimination by probiotic Bacillus via signalling interference","volume":"562","author":"Piewngam","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.micpath.2026.108871_bib201","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2024.1384164","article-title":"Emerging roles of bacteriophage-based therapeutics in combating antibiotic resistance","volume":"15","author":"Subramanian","year":"2024","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2026.108871_bib202","doi-asserted-by":"crossref","DOI":"10.1093\/jlb\/lsad030","article-title":"CRISPR-phage antibacterials to address the antibiotic resistance crisis: scientific, economic, and regulatory considerations","volume":"11","author":"Pacia","year":"2024","journal-title":"J. Law Biosci."},{"key":"10.1016\/j.micpath.2026.108871_bib203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2024.1385261","article-title":"Endolysins: a new antimicrobial agent against antimicrobial resistance. Strategies and opportunities in overcoming the challenges of endolysins against Gram-negative bacteria","volume":"15","author":"Khan","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.micpath.2026.108871_bib204","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.3390\/pharmaceutics16121542","article-title":"Antimicrobial peptides: a promising solution to the rising threat of antibiotic resistance","volume":"16","author":"Islam","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.micpath.2026.108871_bib205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/antibiotics11060816","article-title":"Non-antibiotic drug repositioning as an alternative antimicrobial approach","volume":"11","author":"Barbarossa","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.micpath.2026.108871_bib206","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/cid\/ciag020","article-title":"Assessment of the prioritization of diagnostics in national action plans for antimicrobial resistance","volume":"83","author":"Lamb","year":"2026","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.micpath.2026.108871_bib207","article-title":"Molecular methods for antimicrobial resistance diagnostics to enhance the global antimicrobial resistance surveillance system","year":"2019","journal-title":"World Heal. Organ."},{"key":"10.1016\/j.micpath.2026.108871_bib208","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3390\/microorganisms14030527","article-title":"Operationalising genomic surveillance for antimicrobial resistance in low- and middle-income countries : a one health perspective from Bangladesh","volume":"14","author":"Singh","year":"2026","journal-title":"Microorganisms"},{"key":"10.1016\/j.micpath.2026.108871_bib209","first-page":"4","article-title":"Whole-genome sequencing for surveillance of antimicrobial resistance in Ecuador : present and future implications","volume":"47","author":"Sunyoto","year":"2023","journal-title":"Rev Panam Salud Publica"},{"key":"10.1016\/j.micpath.2026.108871_bib210","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3390\/antibiotics12030523","article-title":"Artificial intelligence for antimicrobial resistance prediction : challenges and opportunities towards practical implementation","volume":"12","author":"Implementation","year":"2023","journal-title":"Antibiotics"},{"key":"10.1016\/j.micpath.2026.108871_bib211","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3390\/idr15030025","article-title":"Modulation of the gut microbiota to control antimicrobial resistance (AMR)\u2014 a narrative review with a focus on faecal microbiota transplantation (FMT)","volume":"15","author":"Merrick","year":"2023","journal-title":"Infect. Dis. Rep."},{"key":"10.1016\/j.micpath.2026.108871_bib212","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/app15095219","article-title":"Microbiome-based interventions for food safety and environmental health","volume":"15","author":"Simon","year":"2025","journal-title":"Appl. Sci."},{"key":"10.1016\/j.micpath.2026.108871_bib213","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2023.28.11.2200367","article-title":"Environmental surveillance of antimicrobial resistance (AMR), perspectives from a national environmental regulator in 2023","volume":"28","author":"Hart","year":"2023","journal-title":"Euro Surveill."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401026005978?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401026005978?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T19:58:52Z","timestamp":1793649532000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401026005978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":213,"alternative-id":["S0882401026005978"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2026.108871","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combating antimicrobial resistance: Emerging non-traditional therapeutics, clinical translation challenges, and future perspectives","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2026.108871","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108871"}}